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Fhis year the Obama administration passed the most
weeping health care reform in a generation. The Health
are and Education Affordability Reconciliation Act of
010 (also known colloquially as “the health care reform
ill”) that was signed into law on March 30, 2010, contains
andates for measuring and improving care through regis-
ries and prospective comparative effectiveness studies (1).
n the context of heart disease, several registries already exist
hose purpose is to examine adherence to care guidelines,
rovide feedback to registry participants, and ultimately
mprove the quality of cardiovascular care that is delivered
or acute coronary syndromes, percutaneous coronary inter-
ention (PCI), carotid artery stenting, coronary artery by-
ass graft surgery, congestive heart failure, and stroke.
See page 8
In this issue of the Journal, the paper by Chan et al. (2)
escribes the American College of Cardiology’s efforts to
easure and improve the quality of cardiovascular care
elivered in the outpatient setting by the PINNACLE
Practice Innovation And Clinical Excellence) program.
his is timely because there has been an increase in the
umbers of outpatients with cardiovascular diagnoses over
ime (3), there will be increased focus on improving the care
hat these patients receive, and this is the first national
utpatient cardiac quality improvement (QI) program in the
.S. The data reported by Chan et al. (2) can be viewed as
ither good news or bad news. Adherence to some perfor-
ance measures, such as blood pressure assessment for
atients with congestive heart failure, was very high
96%). Compliance with other measures was also reason-
bly high: prescription of drug therapy to lower low-density
ipoprotein cholesterol and antiplatelet therapy for patients
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ristol-Myers Squibb, The Medicines Company, Terumo Corp., and AstraZeneca.ith coronary artery disease was 80%. In contrast, there
ppears to be considerable room for improvement in refer-
ing appropriate patients to cardiac rehabilitation and
creening patients for diabetes mellitus.
While these data are interesting and important, the
ublication of the PINNACLE data has greater implica-
ions for the future of QI. This paper represents a “first
ook” at the data from only 27 cardiology practices that
hose to participate in the PINNACLE program. There-
ore, an important message of this paper is the potential that
his registry represents—part of a portfolio of QI programs
hat span the continuum of care from the inpatient to the
utpatient setting. Using the currently available QI tools, a
atient with ischemic cardiomyopathy can have practically
very aspect of their care examined for adherence to practice
uidelines. For example, during an inpatient admission for
cute coronary syndromes, data regarding their manage-
ent can be entered into the NCDR ACTION–Get With
he Guidelines Registry. If they undergo PCI, these data
an be entered into the NCDR CathPCI Registry. If they
ndergo coronary artery bypass graft surgery, the data can
e entered into the Society for Thoracic Surgeons data-
ase. If they receive an implantable cardioverter-
efibrillator, the data can be entered into the NCDR
CD Registry. If they undergo carotid artery stenting, the
ata can be entered into the NCDR CARE Registry.
ow, the quality of the care they receive after hospital-
zation can be evaluated using the PINNACLE program.
What, then, is missing from the QI tool kit? In a word:
ompleteness. Data from registries are unlike data from
linical trials. Clinical trial data are prospectively collected,
arefully monitored and cleaned for completeness and er-
ors, and includes patient identifiers and follow-up. The
rawbacks are well known. Trials have exclusion criteria and
ay not represent some patient subgroups or those who are
nable to consent. Although registries include patients that
ay be excluded from clinical trials, there are limitations to
egistry data that likely lead to overestimation of adherence
o care processes and underestimation of adverse outcomes.
irst, participation in most QI registries is voluntary; not all
ractices or hospitals are represented. Practices and provid-
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Quality Improvement: The PINNACLE Program June 29, 2010:15–7rs who choose to participate in these QI efforts are likely
ifferent from those who choose not to participate. The
ormer may, in fact, deliver higher quality of care simply
ecause they are interested in measuring it. So while we can
ake some reassurance from the rates of compliance with
uideline-recommended therapies described in the paper by
han et al. (2), we should not become complacent, because
hey likely are overestimates of compliance. Second, while
andom data checks are implemented in some registries, the
ate of missing may be relatively high for some data fields.
hat may be compounded by the fact that the data are often
ntered retrospectively from chart review. To account for
his, the definition of certain adverse events such as bleeding
s usually constructed to include data elements that would
ppear in the patient’s chart (e.g., transfusion). If a site does
ot routinely document bleeding events that do not require
ransfusion, then these events are not included in the
egistry data. This is evidenced by a lower rate of peri-PCI
leeding seen in registries compared with in clinical trials
4,5). Similarly, the rate of peri-PCI myocardial infarction
oes not appear to be a reliable performance measure in PCI
egistries where the collection of post-procedure cardiac
arkers is not mandated (6). Third, most QI registries do
ot contain patient identifiers or long-term outcomes be-
ause to do so would require patient consent and approval by
he institutional review board of every participating site.
nstead, they necessarily must sacrifice granularity for
cope—a large amount of less specific data from many sites.
inally, although the quality of care a patient receives can be
xamined comprehensively, doing so requires participation
n several registries (6 in the example cited above). Because
ospitals and practices often pay to participate in QI
egistries, enrolling in every available one may be cost
rohibitive.
How then do we move forward in a world where QI has
ll but become a mandate? The answer lies in 3 principles:
onsistency, completeness, and connectivity. These concepts
ave been outlined broadly by other authors (7) but cannot
e emphasized enough. As mentioned above, the definitions
or similar data elements differ between clinical trials and
egistries. That runs counter to the efforts of both the
rofessional societies and academic groups to standardize
efinitions (8–10). Consistency across trials and registries
ould facilitate QI by enabling an “apples to apples”
ssessment of the safety and effectiveness of evidence-based
herapies. The American College of Cardiology has recently
ndertaken an effort to standardize definitions for data
lements that are common across the NCDR QI programs.
owever, as long as participation in QI registries is volun-
ary, there will never be a complete picture of care processes.
ome have called for mandatory participation in registries
7), and although this is unlikely to be mandated explicitly,
he health care reform bill does contain financial incentives
or hospitals and providers to participate in QI efforts. For
xample, the PINNACLE program is an approved registry
or the Physician Quality Reporting Initiative, a program byhe Centers for Medicare and Medicaid Services that
rovides incentive payments to eligible providers who report
atisfactory performance on certain quality measures. Pro-
iders that participate in PINNACLE have incentive,
herefore, to provide complete information on performance
easures and increase compliance with them to qualify for
igher payment. These financial incentives make it likely
hat the number of participants in QI registries will increase
ver time, and the data flowing into the registries will
ultiply at an exponential rate. However, more information
oes not necessarily mean better information. The constant
river of data” that comes from the registries will have
reater value if there is a system of data monitoring and
onnectivity across registries. It may be easier for a provider,
ractice, or hospital to participate in QI efforts if the data
rom a single patient, like that described in the preceding
ext, can be simultaneously entered into all of the relevant
I programs. At the very least, data fields that are common
cross data collection forms, such as age, sex, medical
istory, and so forth, should be autopopulated in several
atabases. This data infrastructure can also be applied to
rospective clinical investigations in which the registry data
ollection tool can serve as a backbone for case report forms.
uch an effort is already under way (11) and has the
otential to improve the efficiency of both QI programs and
linical trials by avoiding the development of a new data
ollection tool for every new registry or trial. Answering
linical or care process questions can then be achieved by
oing to the “river of information” to obtain the relevant
ata. This is a lofty goal to be sure, and requires a
e-engineering of both clinical trial and QI operations. It
lso requires substantial investment and commitment from
rofessional societies, hospitals, providers, clinical investi-
ators, and governmental and private sponsors of research.
Until now, QI programs have provided snapshots of
linical care. The PINNACLE program serves as a re-
inder that clinical care does not occur in snapshots; it is
ongitudinal, interrelated, and spans across specialties and
iagnoses. In this context, current QI efforts fall somewhat
hort, but with the PINNACLE program, many of the
ecessary pieces are in place to address quality comprehen-
ively. The task now is to tie them together. By addressing
n area of QI that has not been previously dealt with, the
INNACLE program is a step forward and scales new
eights, but more work remains to be done if we are to reach
he summit of quality.
eprint requests and correspondence: Dr. Sunil V. Rao, The
uke Clinical Research Institute, 508 Fulton Street (111A),
urham, North Carolina 27705. E-mail: sunil.rao@duke.edu.
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